* Flt3 Itd (updated 2024-09-21) ~ youtor.org

Flt3 Itd (updated 2024-09-21)

2024年 FLT3ITD基因突變急性血癌最新治療與成功經驗分享 [upl. by Efthim]

2024年 FLT3ITD基因突變急性血癌最新治療與成功經驗分享

Duration: 10:01
978 weergaven | 8 maanden geleden

Maintaining “Intensity” for Better Outcomes in AML [upl. by Paluas]

Maintaining “Intensity” for Better Outcomes in AML

Duration: 1:28:16
816 weergaven | 3 jan. 2023

FLT3 inhibitors in the treatment of AML [upl. by Galer]

FLT3 inhibitors in the treatment of AML

Duration: 1:12
50 weergaven | 16 aug. 2018

A Special Morning Opening in Mrs Nahinus Class [upl. by Wilinski]

A Special Morning Opening in Mrs Nahinus Class

Duration: 7:48
934 weergaven | 22 mei 2016

The importance of predicting venetoclax response in patients with AML [upl. by Jandel]

The importance of predicting venetoclax response in patients with AML

Duration: 1:08
244 weergaven | 11 maanden geleden

Mechanisms of resistance to FLT3 inhibitors in AML and strategies to overcome this [upl. by Yelknirb844]

Mechanisms of resistance to FLT3 inhibitors in AML and strategies to overcome this

Duration: 1:24
47 weergaven | 3 maanden geleden

Maintenance decitabine after intensive therapy for AML in older FLT3ITDnegative patients [upl. by Mutua533]

Maintenance decitabine after intensive therapy for AML in older FLT3ITDnegative patients

Duration: 4:36
172 weergaven | 7 jan. 2020

Randomised trial of the FLT3 inhibitor gilteritinib as posttransplant maintenance for FLT3ITD AML [upl. by Wayne]

Randomised trial of the FLT3 inhibitor gilteritinib as posttransplant maintenance for FLT3ITD AML

Duration: 2:34
62 weergaven | 6 jul. 2023

Comparing midostaurin to nextgeneration FLT3 inhibitors in the frontline treatment of FLT3ITD AML [upl. by Iasi824]

Comparing midostaurin to nextgeneration FLT3 inhibitors in the frontline treatment of FLT3ITD AML

Duration: 2:08
315 weergaven | 10 jul. 2023

【JCF2023】血液がん [upl. by Eveleen]

【JCF2023】血液がん

Duration: 47:55
10,5K weergaven | 1 sep. 2023

Wesley Day at Kitty Ward [upl. by Sigfrid]

Wesley Day at Kitty Ward

Duration: 4:00
3,6K weergaven | 21 mei 2016

Vanflyta® BeyfortusTM CyfendusTM Ycanth™ [upl. by Poole]

Vanflyta® BeyfortusTM CyfendusTM Ycanth™

Duration: 8:45
342 weergaven | 24 jul. 2023

ADMIRAL analysis survival by mutation status in gilteritinibtreated FLT3 RR AML [upl. by Ahsenwahs]

ADMIRAL analysis survival by mutation status in gilteritinibtreated FLT3 RR AML

Duration: 3:21
153 weergaven | 15 jun. 2019

Using a genomewide CRISPR screen to evaluate mechanisms of resistance to FLT3 inhibitors in AML [upl. by Akinod]

Using a genomewide CRISPR screen to evaluate mechanisms of resistance to FLT3 inhibitors in AML

Duration: 2:59
87 weergaven | 28 mrt. 2023

Dr Levis Discusses Quizartinib in AML [upl. by Shiroma]

Dr Levis Discusses Quizartinib in AML

Duration: 2:33
697 weergaven | 3 jan. 2013

【白血病】主治医も驚く数値に上がっていましたDay238【抗がん剤】 [upl. by Natka]

【白血病】主治医も驚く数値に上がっていましたDay238【抗がん剤】

Duration: 2:45
1,8K weergaven | 11 maanden geleden

MORPHO gilteritinib as posttransplant maintenance therapy in patients with FLT3ITD AML [upl. by Neeleuqcaj]

MORPHO gilteritinib as posttransplant maintenance therapy in patients with FLT3ITD AML

Duration: 5:09
737 weergaven | 14 jun. 2023

Best treatment strategy for FLT3 ITD AML [upl. by Pavkovic]

Best treatment strategy for FLT3 ITD AML

Duration: 2:20
1,2K weergaven | 9 jan. 2018

Quizartinib improves overall survival in adult patients with FLT3ITD acute myeloid leukaemia [upl. by Nnyliak956]

Quizartinib improves overall survival in adult patients with FLT3ITD acute myeloid leukaemia

Duration: 3:23
91 weergaven | 15 jun. 2022

Prognostic impact of FLT3ITD in older patients with AML [upl. by Nosyt]

Prognostic impact of FLT3ITD in older patients with AML

Duration: 3:03
307 weergaven | 19 jan. 2023

Acute Myeloid Leukemia [upl. by Chaffee]

Acute Myeloid Leukemia

Duration: 10:43
77 weergaven | 4 maanden geleden

【白血病】⚠️最後に帯状疱疹の映像が映ります⚠️Day568【抗がん剤】 [upl. by Travers659]

【白血病】⚠️最後に帯状疱疹の映像が映ります⚠️Day568【抗がん剤】

Duration: 3:13
1,2K weergaven | 3 weken geleden

【白血病】退院後の近況ご報告骨髄移植Day104【抗がん剤】 [upl. by Melisa162]

【白血病】退院後の近況ご報告骨髄移植Day104【抗がん剤】

Duration: 3:34
2,9K weergaven | 24 mei 2023

【白血病】最近の体調・血液検査・WT1についてDay434【抗がん剤】 [upl. by Airetnohs]

【白血病】最近の体調・血液検査・WT1についてDay434【抗がん剤】

Duration: 7:53
2,3K weergaven | 5 maanden geleden

Why does FLT3 testing need to be performed [upl. by Adnim]

Why does FLT3 testing need to be performed

Duration: 6:12
261 weergaven | 15 jun. 2019

【白血病】炎症数値CRP上昇Day224【抗がん剤】 [upl. by Notsirt]

【白血病】炎症数値CRP上昇Day224【抗がん剤】

Duration: 3:11
1,7K weergaven | 20 sep. 2023

【白血病】新たなる挑戦Day554【抗がん剤】 [upl. by Ameg]

【白血病】新たなる挑戦Day554【抗がん剤】

Duration: 5:01
1,4K weergaven | 1 maand geleden

【白血病】僕の最近の状況Day315【抗がん剤】 [upl. by Maynard]

【白血病】僕の最近の状況Day315【抗がん剤】

Duration: 5:34
1,6K weergaven | 9 maanden geleden

BET and FLT3 inhibitor combinations for FLT3ITD AML [upl. by Hploda]

BET and FLT3 inhibitor combinations for FLT3ITD AML

Duration: 2:43
157 weergaven | 7 jun. 2021

Leucemia mieloide acuta nuove informazioni da studio italiano per l’uso di CPX351 nella real life [upl. by Ackerley]

Leucemia mieloide acuta nuove informazioni da studio italiano per l’uso di CPX351 nella real life

Duration: 7:59
547 weergaven | 8 maanden geleden

YTube is the largest video sharing platform on the Internet. Millions of new videos appear on it every day. You can find a wide variety of videos, but YTube does not offer a FREE download service Our site allows you to download your favorite YTube videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024

1